Both in R&D — Physical & Biological Sciences
iSpecimen vs IB Acquisition
Over the past year ISPC returned −97.4% and IBAC returned +4.0%; their daily moves had a correlation of -0.05.
ISPC −97.4% IBAC +4.0%Growth of $1, one year, split-adjusted
| Metric | ISPC | IBAC |
|---|---|---|
| Price | $0.8740 | $10.86 |
| Market cap | $2.2M | $54.4M |
| Today | +0.22% | 0.00% |
| 1 month | −28.9% | −2.2% |
| 6 months | −79.5% | +0.7% |
| Year to date | −91.6% | +3.4% |
| 1 year | −97.4% | — |
| Revenue growth (YoY) | −78.7% | — |
| Gross margin | 45.2% | — |
| Net margin | −896.9% | — |
| P/E (TTM) | — | — |
| Price / sales | 4.7× | — |
| Net cash | $4.4M | — |
| Dividend yield | — | — |
| Volatility (60d) | 90.1% | 20.1% |
| Short % of float | 10.4% | 0.3% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).